Logo image of DLA

DELTA APPAREL INC (DLA) Stock Fundamental Analysis

NYSEARCA:DLA - NYSE Arca - US2473681037 - Common Stock - Currency: USD

0.58  +0.08 (+16%)

Premarket: 0.4478 -0.13 (-22.79%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DLA. DLA was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of DLA have multiple concerns. DLA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DLA has reported negative net income.
DLA had a positive operating cash flow in the past year.
In multiple years DLA reported negative net income over the last 5 years.
Of the past 5 years DLA 4 years had a positive operating cash flow.
DLA Yearly Net Income VS EBIT VS OCF VS FCFDLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

1.2 Ratios

DLA's Return On Assets of -18.44% is on the low side compared to the rest of the industry. DLA is outperformed by 84.00% of its industry peers.
DLA has a Return On Equity of -63.26%. This is amonst the worse of the industry: DLA underperforms 86.00% of its industry peers.
Industry RankSector Rank
ROA -18.44%
ROE -63.26%
ROIC N/A
ROA(3y)0.38%
ROA(5y)0.16%
ROE(3y)0.36%
ROE(5y)-0.19%
ROIC(3y)N/A
ROIC(5y)N/A
DLA Yearly ROA, ROE, ROICDLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

With a Gross Margin value of 10.18%, DLA is not doing good in the industry: 96.00% of the companies in the same industry are doing better.
DLA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for DLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.18%
GM growth 5Y-8.91%
DLA Yearly Profit, Operating, Gross MarginsDLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

More info and screens

3

2. Health

2.1 Basic Checks

DLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
DLA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DLA has been increased compared to 5 years ago.
Compared to 1 year ago, DLA has a worse debt to assets ratio.
DLA Yearly Shares OutstandingDLA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
DLA Yearly Total Debt VS Total AssetsDLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

DLA has an Altman-Z score of 1.03. This is a bad value and indicates that DLA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DLA (1.03) is worse than 76.00% of its industry peers.
The Debt to FCF ratio of DLA is 1.98, which is an excellent value as it means it would take DLA, only 1.98 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 1.98, DLA perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that DLA is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.15, DLA is doing good in the industry, outperforming 64.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.98
Altman-Z 1.03
ROIC/WACCN/A
WACC6.87%
DLA Yearly LT Debt VS Equity VS FCFDLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

DLA has a Current Ratio of 1.01. This is a normal value and indicates that DLA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.01, DLA is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.21 indicates that DLA may have some problems paying its short term obligations.
With a Quick ratio value of 0.21, DLA is not doing good in the industry: 98.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.21
DLA Yearly Current Assets VS Current LiabilitesDLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

DLA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -423.30%.
The Revenue for DLA has decreased by -22.49% in the past year. This is quite bad
Measured over the past years, DLA shows a small growth in Revenue. The Revenue has been growing by 0.99% on average per year.
EPS 1Y (TTM)-423.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-153%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y2.92%
Revenue growth 5Y0.99%
Sales Q2Q%-28.45%

3.2 Future

The Earnings Per Share is expected to grow by 34.37% on average over the next years. This is a very strong growth
Based on estimates for the next years, DLA will show a decrease in Revenue. The Revenue will decrease by -3.00% on average per year.
EPS Next Y34.98%
EPS Next 2Y34.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.35%
Revenue Next 2Y-3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DLA Yearly Revenue VS EstimatesDLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
DLA Yearly EPS VS EstimatesDLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

DLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DLA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DLA Price Earnings VS Forward Price EarningsDLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than DLA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.06
EV/EBITDA N/A
DLA Per share dataDLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

DLA's earnings are expected to grow with 34.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.37%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DLA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DELTA APPAREL INC

NYSEARCA:DLA (6/28/2024, 8:04:00 PM)

Premarket: 0.4478 -0.13 (-22.79%)

0.58

+0.08 (+16%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-08 2024-05-08/amc
Earnings (Next)08-01 2024-08-01/amc
Inst Owners0.99%
Inst Owner Change25%
Ins Owners15.21%
Ins Owner Change0%
Market Cap4.09M
Analysts80
Price Target8.16 (1306.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.94%
Min EPS beat(2)-155.61%
Max EPS beat(2)-2.27%
EPS beat(4)0
Avg EPS beat(4)-206.67%
Min EPS beat(4)-642.57%
Max EPS beat(4)-2.27%
EPS beat(8)0
Avg EPS beat(8)-140.72%
EPS beat(12)4
Avg EPS beat(12)-73.12%
EPS beat(16)8
Avg EPS beat(16)-24.1%
Revenue beat(2)0
Avg Revenue beat(2)-16.43%
Min Revenue beat(2)-18.41%
Max Revenue beat(2)-14.44%
Revenue beat(4)0
Avg Revenue beat(4)-12.24%
Min Revenue beat(4)-18.41%
Max Revenue beat(4)-6.7%
Revenue beat(8)1
Avg Revenue beat(8)-8.29%
Revenue beat(12)4
Avg Revenue beat(12)-4.6%
Revenue beat(16)4
Avg Revenue beat(16)-3.65%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.06
P/OCF 0.06
P/B 0.04
P/tB 0.06
EV/EBITDA N/A
EPS(TTM)-5.39
EYN/A
EPS(NY)-0.74
Fwd EYN/A
FCF(TTM)9.08
FCFY1565.1%
OCF(TTM)9.37
OCFY1615.21%
SpS50.58
BVpS15.13
TBVpS9.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.44%
ROE -63.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.18%
FCFM 17.95%
ROA(3y)0.38%
ROA(5y)0.16%
ROE(3y)0.36%
ROE(5y)-0.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.18%
GM growth 5Y-8.91%
F-Score4
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.98
Debt/EBITDA N/A
Cap/Depr 13.98%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.21
Altman-Z 1.03
F-Score4
WACC6.87%
ROIC/WACCN/A
Cap/Depr(3y)63.4%
Cap/Depr(5y)62.44%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-423.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-153%
EPS Next Y34.98%
EPS Next 2Y34.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y2.92%
Revenue growth 5Y0.99%
Sales Q2Q%-28.45%
Revenue Next Year-11.35%
Revenue Next 2Y-3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1027.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year177.99%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y856.11%
FCF growth 3Y-28.33%
FCF growth 5Y-11.5%
OCF growth 1Y544.16%
OCF growth 3Y-29.34%
OCF growth 5Y-11.99%